Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2
Approvals & regulatory · first seen yesterday, updated yesterday

Thank you Analysis Life Sciences FDA launches expedited IND pilot, fills in details on its design

1 outlet FDA

FDA launches expedited IND pilot, fills in details on its design #jv-layout-id_9f7043-c4 > .jv-row-column-wrap {padding-top:3%;padding-bottom:0%;padding-left:23%;padding-right:23%;}@media (min-width: 768px) and (max-width: 1024px) {#jv-layo…

Summary from AgencyIQ.

Coverage 2 articles · 1 outlet

  1. AgencyIQ
    Thank you Analysis Life Sciences FDA launches expedited IND pilot, fills in details on its design
  2. AgencyIQ
    Analysis Life Sciences FDA launches expedited IND pilot, fills in details on its design